Mónica Galli

8.4k total citations · 2 hit papers
60 papers, 3.2k citations indexed

About

Mónica Galli is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mónica Galli has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 28 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Mónica Galli's work include Multiple Myeloma Research and Treatments (40 papers), Cancer Treatment and Pharmacology (22 papers) and Protein Degradation and Inhibitors (10 papers). Mónica Galli is often cited by papers focused on Multiple Myeloma Research and Treatments (40 papers), Cancer Treatment and Pharmacology (22 papers) and Protein Degradation and Inhibitors (10 papers). Mónica Galli collaborates with scholars based in Italy, United States and Switzerland. Mónica Galli's co-authors include Tiziano Barbui, Armando Tripodi, Thomas L. Ortel, Philip G. de Groot, Jacob H. Rand, Vittorio Pengo, Guido Reber, Marc H. De Baets, R.F.A. Zwaal and Edouard M. Bevers and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Mónica Galli

58 papers receiving 3.1k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1990 1.0k citations Mónica Galli, Tiziano Barbui et al. profile →
Update of the guidelines for lupus anticoagulant detection

2009 855 citations Vittorio Pengo, Armando Tripodi et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mónica Galli Italy	19	2.0k	1.7k	696	506	469	60	3.2k
Marielle Sanmarco France	26	1.6k 0.8×	1.2k 0.7×	459 0.7×	775 1.5×	612 1.3×	48	2.8k
G Spencer-Green United States	19	2.8k 1.4×	1.1k 0.6×	385 0.6×	510 1.0×	908 1.9×	40	4.1k
Martin Grießhammer Germany	34	1.3k 0.7×	2.4k 1.4×	180 0.3×	1.6k 3.1×	185 0.4×	153	4.1k
Sergio Cortelazzo Italy	31	695 0.4×	1.5k 0.9×	99 0.1×	739 1.5×	477 1.0×	117	4.5k
Enrico Maria Pogliani Italy	26	452 0.2×	1.4k 0.8×	80 0.1×	533 1.1×	318 0.7×	96	2.7k
Jiuliang Zhao China	24	1.2k 0.6×	234 0.1×	189 0.3×	286 0.6×	570 1.2×	231	2.3k
Carol A. Connell United States	17	2.6k 1.3×	1.3k 0.7×	158 0.2×	221 0.4×	866 1.8×	39	3.8k
Nichola Cooper United Kingdom	33	232 0.1×	5.9k 3.4×	220 0.3×	260 0.5×	1.3k 2.7×	141	7.2k
Michael H. Rosove United States	18	486 0.2×	483 0.3×	85 0.1×	122 0.2×	208 0.4×	40	1.9k
Enrico Pogliani Italy	25	451 0.2×	1.7k 1.0×	46 0.1×	431 0.9×	426 0.9×	75	2.9k

Countries citing papers authored by Mónica Galli

Since Specialization

Citations

This map shows the geographic impact of Mónica Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Galli more than expected).

Fields of papers citing papers by Mónica Galli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Galli. The network helps show where Mónica Galli may publish in the future.

Co-authorship network of co-authors of Mónica Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Galli. A scholar is included among the top collaborators of Mónica Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Galli. Mónica Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galli, Mónica, Laura París, Chiara Pavoni, et al.. (2023). Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis. Blood. 142(Supplement 1). 4706–4706. 2 indexed citations

Cattaneo, Irene, Rut Valgardsdottir, Roberta Cavagna, et al.. (2023). Genetic defects of gamma‐secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report. British Journal of Haematology. 204(2). 571–575. 3 indexed citations

Montefusco, Vittorio, Alessandro Corso, Mónica Galli, et al.. (2020). Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse. British Journal of Haematology. 188(6). 907–917. 7 indexed citations

Pompa, Alessandra, Laura París, Francesca Guidotti, et al.. (2017). Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation. Blood. 130. 4476–4476. 1 indexed citations

Scalabrini, Delia Rota, Angelo Belotti, Massimo Offidani, et al.. (2017). Carfilzomib-lenalidomide-dexamethasone (KRd) vs carfilzomib-cyclophosphamide-dexamethasone (KCd) induction: Planned interim analysis of the randomized FORTE trial in newly diagnosed multiple myeloma (NDMM).. Journal of Clinical Oncology. 35(15_suppl). 8003–8003. 14 indexed citations

Montefusco, Vittorio, Alessandro Corso, Mónica Galli, et al.. (2017). Bortezomib/Cyclophosphamide/Dexamethasone Versus Lenalidomide/Cyclophosphamide/Dexamethasone in Multiple Myeloma Patients at First Relapse: Final Results of a Phase III Study. Blood. 130(Suppl_1). 836–836. 2 indexed citations

Buoro, Sabrina, et al.. (2016). Abnormal leukocyte scattergrams and immature platelet fraction on Sysmex XN-9000 analyzer: a new diagnostic tool for altered megakaryopoiesis?. Scandinavian Journal of Clinical and Laboratory Investigation. 77(1). 73–75. 4 indexed citations

Galli, Mónica, Federica Lessi, Alessandro Rambaldi, et al.. (2015). Mobilization of peripheral blood hematopoietic stem cells by granulocyte-colony stimulating factor and plerixafor in patients with cardiac AL amyloidosis. Amyloid. 22(4). 259–260. 2 indexed citations

Montefusco, Vittorio, Mónica Galli, Francesco Spina, et al.. (2014). Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Leukemia & lymphoma. 55(9). 2032–2037. 16 indexed citations

10.

Larocca, Alessandra, Vittorio Montefusco, Sara Bringhen, et al.. (2013). Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. Blood. 122(16). 2799–2806. 66 indexed citations

11.

Cavo, Michèle, Mónica Galli, Annalisa Pezzi, et al.. (2013). Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study. Blood. 122(21). 2090–2090. 6 indexed citations

12.

Galli, Mónica. (2013). Treatment of the antiphospholipid syndrome. PubMed. 5(1). 1–7. 10 indexed citations

13.

Corso, Alessandro, Mónica Galli, Silvia Mangiacavalli, et al.. (2011). Response‐adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression‐free survival in transplanted patients with multiple myeloma. American Journal of Hematology. 87(2). 150–154. 8 indexed citations

14.

Cavallo, Federica, Francesco Di Raimondo, Barbara Lupo, et al.. (2010). A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen.. Blood. 116(21). 1092–1092. 8 indexed citations

15.

Pengo, Vittorio, Armando Tripodi, Guido Reber, et al.. (2009). Update of the guidelines for lupus anticoagulant detection. Journal of Thrombosis and Haemostasis. 7(10). 1737–1740. 855 indexed citations breakdown →

16.

Palumbo, Antonio, Sara Bringhen, D Rossi, et al.. (2009). A phase III study of VMPT versus VMP in newly diagnosed elderly myeloma patients. Journal of Clinical Oncology. 27(15_suppl). 8515–8515. 11 indexed citations

17.

Giavazzi, Raffaella, Angela Garofalo, Teresio Motta, et al.. (1995). Establishment of human acute myelogenous leukemia lines secreting interleukin‐1β in SCID mice. International Journal of Cancer. 61(2). 280–285. 13 indexed citations

18.

Bianchi, Simonetta, Domenico Palli, Stefano Ciatto, et al.. (1995). Accuracy and Reliability of Frozen Section Diagnosis in a Series of 672 Nonpalpable Breast Lesions. American Journal of Clinical Pathology. 103(2). 199–205. 45 indexed citations

19.

Bianchi, Simonetta, Domenico Palli, Mónica Galli, et al.. (1994). Reproducibility of histological diagnoses and diagnostic accuracy of non palpable breast lesions. Pathology - Research and Practice. 190(1). 69–76. 18 indexed citations

20.

Finazzi, Guido, Anna Falanga, Mónica Galli, et al.. (1994). Recombinant Versus High-sensitivity Conventional Thromboplastin: A Randomized Clinical Study in Patients on Oral Anticoagulation. Thrombosis and Haemostasis. 72(6). 804–807. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact